Clinical outcomes after ABO-incompatible renal transplantation - Authors' reply

Affiliations

¹ Clinic of Nephrology and Hypertension, Diabetology and Endocrinology, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke-University Magdeburg, 39120 Magdeburg, Germany.
² Clinic of Nephrology and Hypertension, Diabetology and Endocrinology, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke-University Magdeburg, 39120 Magdeburg, Germany. Electronic address: christos.chatzikyrkou@med.ovgu.de.

Comment

Florian Gunnar Scurt et al. Lancet. 2019.

. 2019 Nov 30;394(10213):1989-1990.

doi: 10.1016/S0140-6736(19)32592-9.

¹ Clinic of Nephrology and Hypertension, Diabetology and Endocrinology, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke-University Magdeburg, 39120 Magdeburg, Germany.
² Clinic of Nephrology and Hypertension, Diabetology and Endocrinology, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke-University Magdeburg, 39120 Magdeburg, Germany. Electronic address: christos.chatzikyrkou@med.ovgu.de.

No abstract available

Comment on

Clinical outcomes after ABO-incompatible renal transplantation.
Loupy A, Bouquegneau A, Stegall MD, Montgomery RA. Loupy A, et al. Lancet. 2019 Nov 30;394(10213):1988-1989. doi: 10.1016/S0140-6736(19)32490-0. Lancet. 2019. PMID: 31789213 No abstract available.
Clinical outcomes after ABO-incompatible renal transplantation.
Morath C, Zschiedrich S, Speer C, Zeier M, Döhler B, Opelz G, Süsal C. Morath C, et al. Lancet. 2019 Nov 30;394(10213):1989. doi: 10.1016/S0140-6736(19)32492-4. Lancet. 2019. PMID: 31789216 No abstract available.